期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 57, 期 3, 页码 312-316出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2018-0610
关键词
circulating tumor cells; liquid biopsy; minimal residual disease
资金
- EU/IMI consortium CANCER-ID, an Innovative Medicines Initiative Joint Undertaking [115749]
- European Union's Seventh Framework Programme (FP7 Health/2007-2013)
Liquid biopsy was introduced as a new diagnostic concept in 2010 for the analysis of circulating tumor cells (CTCs) and has been now extended to material (in particular DNA) released by tumor cells in the peripheral blood of cancer patients. Over the past decade, various methods have been developed to detect CTCs and ctDNA in the peripheral blood of cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
